NCT01717001

Brief Summary

A better understanding of knee joint kinematics is important to explain the premature polyethylene wear failures within total knee arthroplasties (TKAs) and to help design a prosthesis that most closely approximates the normal knee. Previously, most experimental studies of knee kinematics have involved cadaveric, in vitro analyses, or have not tested the knee in a weight-bearing mode. Others have used exoskeletal linkages and skin markers that permit error due to undesired motions between markers and the underlying bone. More recently, fluoroscopy has been used to assess in vivo kinematics for subjects having a TKA. ConforMIS has attempted to follow a clearly different path than the major orthopaedic companies. They have chosen to offer patients a personalized knee implant based off of each patient's femoral and tibial bone geometry. The hypothesis is that these subjects will experience a more normal-like kinematic pattern, eliminating paradoxical anterior sliding during weight-bearing knee flexion. Therefore, the objective for this study is to analyze the in vivo kinematics for 25 patients implanted with a personalized ConforMIS TKA and 25 patients implanted with a traditional TKA design to determine if there are any kinematic differences between these TKA designs.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2012

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2012

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

October 26, 2012

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 30, 2012

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2014

Completed
6.4 years until next milestone

Results Posted

Study results publicly available

December 31, 2020

Completed
Last Updated

October 25, 2023

Status Verified

October 1, 2023

Enrollment Period

2 years

First QC Date

October 26, 2012

Results QC Date

December 2, 2020

Last Update Submit

October 23, 2023

Conditions

Keywords

kinematicsknee joint

Outcome Measures

Primary Outcomes (1)

  • Post-operative Range of Motion

    Comparison of amount of flexion achieved by the knee between the two arms

    at least 6 months post-surgery

Study Arms (2)

ConforMIS

Patients with ConforMIS implants

Standard Total Knee Implant

Patients implanted with standard total knee implant

Eligibility Criteria

Age40 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who are at least 6 month post-op with a ConforMIS knee replacement or a standard total knee replacement who meets the inclusion/exclusion criteria

You may qualify if:

  • At least 6 months post-op with no other surgical procedures conducted within the past 6 months
  • Between 40-70 years of age
  • Body weight of less than 250lbs
  • BMI of less than 38
  • Pregnant females will be excluded
  • TKA patients will be judged Clinically successful with an American Knee Society score of greater than 90
  • Must have 100 degrees post-op passive flexion with no ligamentous laxity or pain
  • Participants must be able to walk on level ground without aid of any kind and ascend/descend stairs without assistance.
  • All potential subjects will have either a personalized ConforMIS™ TKA or a traditional TKA manufactured by an orthopaedic company other than ConforMIS.
  • Patients from the physician's list who do not meet the study requirements will not be considered.
  • Patients must be willing to sign the Informed Consent and HIPAA forms to participate in the study.
  • Patients must be between 160cm (5'3) and 193cm (6'4) tall.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University of Tennessee

Knoxville, Tennessee, 37996, United States

Location

Tennessee Orthopedic Alliance

Nashville, Tennessee, 37203, United States

Location

MeSH Terms

Conditions

Osteoarthritis

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Results Point of Contact

Title
Rebecca Robertson
Organization
University of Tennessee

Study Officials

  • Richard D Komistek, PhD

    Univeristy of Tennessee

    PRINCIPAL INVESTIGATOR
  • William Kurtz, MD

    Tennessee Orthopedic Alliance

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 26, 2012

First Posted

October 30, 2012

Study Start

August 1, 2012

Primary Completion

August 1, 2014

Study Completion

August 1, 2014

Last Updated

October 25, 2023

Results First Posted

December 31, 2020

Record last verified: 2023-10

Data Sharing

IPD Sharing
Will not share

Locations